<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1382389</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2024.1382389</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>In vitro</italic> co-culture of <italic>Clostridium scindens</italic> with primary human colonic epithelium protects the epithelium against <italic>Staphylococcus aureus</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1382389">10.3389/fbioe.2024.1382389</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Raehyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1748913/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yuli</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Furtado</surname>
<given-names>Kathleen L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2652920/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sims</surname>
<given-names>Christopher E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamayo</surname>
<given-names>Rita</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/15949/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Allbritton</surname>
<given-names>Nancy L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/856359/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Bioengineering</institution>, <institution>University of Washington</institution>, <addr-line>Seattle</addr-line>, <addr-line>WA</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Biological and Chemical Engineering</institution>, <institution>Hongik University</institution>, <addr-line>Sejong</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Microbiology and Immunology</institution>, <institution>University of North Carolina</institution>, <addr-line>Chapel Hill</addr-line>, <addr-line>NC</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Medicine/Division of Rheumatology</institution>, <institution>University of Washington</institution>, <addr-line>Seattle</addr-line>, <addr-line>WA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/823476/overview">Nic Davis Leipzig</ext-link>, University of Akron, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/604559/overview">Mindy Engevik</ext-link>, Medical University of South Carolina, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/645184/overview">Shaohua Wang</ext-link>, Ohio University, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Nancy L. Allbritton, <email>nlallbr@uw.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1382389</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Wang, Kim, Wang, Furtado, Sims, Tamayo and Allbritton.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wang, Kim, Wang, Furtado, Sims, Tamayo and Allbritton</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>A complex and dynamic network of interactions exists between human gastrointestinal epithelium and intestinal microbiota. Therefore, comprehending intestinal microbe-epithelial cell interactions is critical for the understanding and treatment of intestinal diseases. Primary human colonic epithelial cells derived from a healthy human donor were co-cultured with <italic>Clostridium scindens</italic> (<italic>C. scindens</italic>), a probiotic obligate anaerobe; <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>), a facultative anaerobe and intestinal pathogen; or both bacterial species in tandem. The co-culture hanging basket platform used for these experiments possessed walls of controlled oxygen (O<sub>2</sub>) permeability to support the formation of an O<sub>2</sub> gradient across the intestinal epithelium using cellular O<sub>2</sub> consumption, resulting in an anaerobic luminal and aerobic basal compartment. Both the colonic epithelial cells and <italic>C. scindens</italic> remained viable over 48&#xa0;h during co-culture. In contrast, co-culture with <italic>S. aureus</italic> elicited significant damage to colonic epithelial cells within 24&#xa0;h. To explore the influence of the intestinal pathogen on the epithelium in the presence of the probiotic bacteria, colonic epithelial cells were inoculated sequentially with the two bacterial species. Under these conditions, <italic>C. scindens</italic> was capable of repressing the production of <italic>S. aureus</italic> enterotoxin. Surprisingly, although <italic>C. scindens</italic> converted cholic acid to secondary bile acids in the luminal medium, the growth of <italic>S. aureus</italic> was not significantly inhibited. Nevertheless, this combination of probiotic and pathogenic bacteria was found to benefit the survival of the colonic epithelial cells compared with co-culture of the epithelial cells with <italic>S. aureus</italic> alone. This platform thus provides an easy-to-use and low-cost tool to study the interaction between intestinal bacteria and colonic cells <italic>in vitro</italic> to better understand the interplay of intestinal microbiota with human colonic epithelium.</p>
</abstract>
<kwd-group>
<kwd>intestine</kwd>
<kwd>gut microbiome</kwd>
<kwd>multi-species culture</kwd>
<kwd>oxygen gradient</kwd>
<kwd>bile acid</kwd>
<kwd>enterotoxin</kwd>
<kwd>interactions</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Organoids and Organ-On-A-Chip</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The colon receives partially digested food from the small intestine and absorbs water and residual nutrients, subsequently transporting indigestible waste in the form of feces for elimination (<xref ref-type="bibr" rid="B3">Azzouz and Sharma, 2022</xref>). The colon is lined with a monolayer of epithelial cells that form a barrier between luminal contents and the host while maintaining an anaerobic environment within the lumen (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>). Additionally, the colon has less fluid and the lowest average flow rate of the intestinal system (<xref ref-type="bibr" rid="B28">Harris and Scolapio, 2019</xref>). Based on these features, the colon provides an ideal growth environment for a complex microbial community that includes obligate and facultative anaerobic species and whose composition and metabolism are influenced by diet and host factors. In turn, this microbial community contributes to human metabolism through fermentation of undigested fiber (<xref ref-type="bibr" rid="B11">Clarke et al., 2014</xref>), production of vitamins (<xref ref-type="bibr" rid="B26">Guarner and Malagelada, 2003</xref>; <xref ref-type="bibr" rid="B3">Azzouz and Sharma, 2022</xref>), absorption of minerals (<xref ref-type="bibr" rid="B26">Guarner and Malagelada, 2003</xref>), and transformation of bile acids (<xref ref-type="bibr" rid="B57">Ridlon et al., 2014</xref>). Commensal microbiota also plays an essential role in the defense against pathogens (<xref ref-type="bibr" rid="B9">Cheng et al., 2020</xref>; <xref ref-type="bibr" rid="B33">Khan et al., 2021</xref>). Known mechanisms in this defense include direct pathogen inhibition by metabolic products of commensal microbes (<xref ref-type="bibr" rid="B60">Rooks and Garrett, 2016</xref>), outcompeting pathogens for nutrients and other resources that limit pathogen growth (<xref ref-type="bibr" rid="B70">Stubbendieck and Straight, 2016</xref>), formation of a microbial barrier in the mucosal layer (<xref ref-type="bibr" rid="B68">Sommer and B&#xe4;ckhed, 2013</xref>), and directing the immune system towards elimination of pathogens (<xref ref-type="bibr" rid="B5">Baruch et al., 2021</xref>; <xref ref-type="bibr" rid="B15">Davar et al., 2021</xref>). Commensal microbes also interact with and regulate the colonic epithelium itself, influencing cell turnover, promoting epithelial restitution, and reorganization of tight junctions (<xref ref-type="bibr" rid="B82">Yu et al., 2012</xref>). In contrast, pathogenic microbes have the potential to degrade the mucus barrier and invade the mucosal epithelium; these pathogens cause or are associated with various intestine-associated diseases, including gastroenteritis, inflammatory bowel disease (IBD), pancreatitis, and cancer (<xref ref-type="bibr" rid="B66">Shu et al., 2023</xref>). Therefore, understanding host-microbiota interactions is essential for the preservation of human health and may lead to effective approaches to mitigate intestinal diseases.</p>
<p>The interactions between host and intestinal microbiota are often studied using animal models. To limit or prevent intestinal microbe colonization, animals are either raised in a germ-free environment and/or exposed to antibiotic treatment to allow control of microflora during experiments (<xref ref-type="bibr" rid="B67">Sivan et al., 2015</xref>). The most common animal model is the mouse due primarily to accessibility and low maintenance cost (<xref ref-type="bibr" rid="B49">Nguyen et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Li and Zhang, 2022</xref>). The porcine model has a more comparable colonic structure, hormone secretion, and gut microbiota composition to the human (<xref ref-type="bibr" rid="B29">Heinritz et al., 2013</xref>; <xref ref-type="bibr" rid="B61">Roura et al., 2016</xref>), which makes the pig a popular, albeit costly, animal model. Although animal models have been commonly used in gut microbiome research for decades, ethical and cost issues, their distinct genetics, intestinal structure, microbiota composition, and immune responses impose limitations on these models for understanding human/microbiome physiology and pathophysiology (<xref ref-type="bibr" rid="B41">Marrero et al., 2021</xref>). <italic>In lieu</italic> of animal models, <italic>in vitro</italic> fermentation systems using reactor chambers are cost-effective platforms for intestinal microbiota studies (<xref ref-type="bibr" rid="B39">Li and Zhang, 2022</xref>). These batch or continuous flow systems enable precise control of physiological parameters within the system, such as pH, temperature, retention time, composition of the media, and anaerobic conditions (<xref ref-type="bibr" rid="B52">Payne et al., 2012</xref>). Multistage fermentation models enable the simulation of the different luminal physiological environments from the stomach to the colon in the absence of intestinal epithelium (<xref ref-type="bibr" rid="B74">Verhoeckx et al., 2015</xref>). However, these systems are unsuitable for assessing interactions with the host gastrointestinal tissue. To address this limitation, viable intestinal segments from animals have been integrated into fluidic systems to assemble <italic>ex vivo</italic> models, such as the Ussing chamber and the everted gut sac model, although these systems have many challenges, including their size, operational complexity, and the absence of human intestinal epithelium (<xref ref-type="bibr" rid="B12">Clarke, 2009</xref>; <xref ref-type="bibr" rid="B1">Alam et al., 2012</xref>; <xref ref-type="bibr" rid="B55">Rahman et al., 2021</xref>).</p>
<p>To replicate the interaction between human intestine and gut microbiota, <italic>in vitro</italic> models combining microfluidic platforms and co-culture of primary human intestinal cells with gut bacteria have been developed. These systems have been used to create a more complex environment for intestinal microbiota by perfusing oxygenated and deoxygenated media in separate compartments to create an O<sub>2</sub> gradient and fluidic shear stress, as well as to prevent bacterial overgrowth and to collect secreted molecules (<xref ref-type="bibr" rid="B73">Tovaglieri et al., 2019</xref>; <xref ref-type="bibr" rid="B85">Zhang et al., 2021b</xref>). Despite their potential, the complex, sterile flow systems and enclosed structure (with inaccessible compartments) present barriers in their use. Organoids embedded in Matrigel&#x2122; formed from differentiated gastrointestinal stem cells have been used to model an internal cavity representing the gut lumen, with live bacteria inoculated through microinjection (<xref ref-type="bibr" rid="B4">Bartfeld et al., 2015</xref>; <xref ref-type="bibr" rid="B80">Williamson et al., 2018</xref>). Shortcomings of these models are the difficulty of accessing the luminal compartment, an uncontrolled luminal O<sub>2</sub> concentration, and overgrowth of the confined microbiota. To partially address these limitations, the polarity of organoids has been reversed by disrupting the polymerization of the ECM proteins to create &#x201c;luminal-out&#x201d; organoids embedded in media (<xref ref-type="bibr" rid="B13">Co et al., 2019</xref>). Luminal-out organoids can be transferred to media containing microbes to achieve co-culture experiments, but this organoid system lacks the ability to create the low-O<sub>2</sub> concentration needed to support anaerobic bacteria and presents further challenges in controlling and sampling the embedded tissue mimic.</p>
<p>Hanging basket systems have been applied to investigate host-bacteria interactions (<xref ref-type="bibr" rid="B59">Roodsant et al., 2020</xref>; <xref ref-type="bibr" rid="B63">Sasaki et al., 2020</xref>; <xref ref-type="bibr" rid="B84">Zhang et al., 2021a</xref>). The double-sided design of this platform, with luminal and basal compartments separated by a monolayer of mammalian gastrointestinal epithelial cells, makes it feasible to mimic the luminal-epithelial structure of intestinal tissue and eases inoculating microbiota and sampling the luminal and basal environments (<xref ref-type="bibr" rid="B19">Dutton et al., 2019</xref>; <xref ref-type="bibr" rid="B71">&#x160;uligoj et al., 2020</xref>). Recently, a hanging basket system with an oxygenated basal reservoir and deoxygenated luminal compartment was shown to form an O<sub>2</sub> gradient across a primary human colonic epithelium; this system supported the human epithelial cells while enabling co-culture of obligate anaerobic bacteria in the luminal compartment (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="B35">Kim et al., 2022</xref>). This platform does not require continuous perfusion of the media and allows routine sampling and replenishment of both luminal and basal environments when used in combination with an anaerobic chamber, making it attractive and accessible to a broad group of users. However, to date, co-culture of the human epithelium with only a single strain of bacteria for a short duration (24&#xa0;h) has been demonstrated with this system. In the current study, we extend the lifetime of co-culture to 48&#xa0;h with the commensal bacterium <italic>Clostridium scindens</italic> and with the pathogen <italic>Staphylococcus aureus</italic> when the bacteria are co-cultured in tandem. The goal of this experimental work is to determine whether a colonic commensal obligate anaerobe can be co-cultured in the presence of living primary human colonic epithelial cells with high viability and metabolic activity, and whether this co-culture affords protection to the colonic epithelium in the presence of pathogenic bacteria.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Fabrication of an O<sub>2</sub> gradient cassette with a supporting collagen matrix</title>
<p>The O<sub>2</sub> gradient cassette was composed of a basal fluid reservoir, a customized hanging basket (similar to a Transwell insert) placed into the basal reservoir, and an O<sub>2</sub>-impermeable machined plug for insertion into the luminal portion of the hanging basket (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>). A conventional 12-well plate was used for the basal reservoirs. The design and fabrication of the hanging basket was similar to that described previously (<xref ref-type="bibr" rid="B27">Gunasekara et al., 2018</xref>; <xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>). Briefly, the hanging basket was fabricated from polycarbonate using a CNC milling machine. Next, a porous polyester (PET) membrane (0.4&#xa0;&#xb5;m pores, Sterlitech Cat &#x23;1300016) was attached to the bottom of the hanging basket using double-sided medical grade tape (3M, Cat &#x23;1504XL). Five minutes of plasma treatment (Harrick Plasma, Cat &#x23;PDC-32G) improved adhesion of subsequently added collagen to the basket. The basket with 200&#xa0;&#xb5;L neutralized collagen (rat tail, type I, Corning, Cat &#x23;354236) solution (1&#xa0;mg/mL) (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="B35">Kim et al., 2022</xref>) was incubated for 1&#xa0;h at 37&#xb0;C and then submerged in 3&#xa0;mL crosslinking solution added to the basal reservoir for 30&#xa0;min at 25&#xb0;C. The crosslinking solution was 0.6&#xa0;M 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC): 0.15&#xa0;M&#xa0;N-hydroxysuccinimide (NHS): 0.1&#xa0;M 2-(N-morpholino) ethanesulfonic acid (MES) buffer (pH 5.0) in water, (1:1:1 (vol). Later, the basket with partially crosslinked collagen matrix (1.1&#xa0;cm<sup>2</sup> of surface area and 2.2&#xa0;mm of thickness (<xref ref-type="bibr" rid="B27">Gunasekara et al., 2018</xref>)) was incubated in deionized water for &#x3e;18&#xa0;h at 25&#xb0;C to leach out residual crosslinking reagent followed by sterilization in 70% ethanol and was then air-dried in a biosafety cabinet. The basket with collagen matrix could be stored in PBS buffer at 4&#xb0;C for 2&#x2013;3 weeks before adding the human primary colon cells. The cells were cultured aerobically to form a confluent monolayer on the collagen/PET membrane scaffold submerged in a well of the 12-well plate (see below). For O<sub>2</sub> gradient, an O<sub>2</sub>-impermeable plug fabricated from polycarbonate was threaded into the luminal portion of the basket. A soft Viton<sup>&#xae;</sup> fluoroelastomer O-ring (McMaster Car, Cat &#x23;1284N114) was used with the plug to form an O<sub>2</sub>-impermeable seal. A port in the plug was used for insertion of an O<sub>2</sub> probe, and this port was sealed with ethylene propylene diene monomer (EPDM) rubber caps (McMaster-Carr, Cat &#x23;6448K117) when an O<sub>2</sub> sensor was not in place. The O<sub>2</sub> probe in the luminal compartment was a needle O<sub>2</sub> probe (PreSens, NTH-PSt7/Microx4, Germany). The tip of the probe was submerged into the luminal media to approximately 2&#xa0;mm above the epithelial monolayer when O<sub>2</sub> was measured.</p>
</sec>
<sec id="s2-2">
<title>2.2 Human primary colon epithelial cell culture</title>
<p>Primary human colonic epithelial stem cells from the transverse colon of a cadaveric donor (male, 23 years old, RRID: CVCL_ZR41 (<ext-link ext-link-type="uri" xlink:href="https://web.expasy.org/cellosaurus/CVCL_ZR41">https://web.expasy.org/cellosaurus/CVCL_ZR41</ext-link>)) were isolated, expanded, and maintained on a collagen scaffold in a 6-well plate in a stem cell media (SM, <xref ref-type="sec" rid="s11">Supplementary Table S1</xref>) as described previously (<xref ref-type="bibr" rid="B75">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>). Cells were used between passage 7 and 12. For each experiment, the human colonic stem cells were sub-cultured from a single well of the maintenance culture into 6 hanging baskets with collagen matrix prepared as described above. The human colonic cells were expanded on the collagen matrix in the hanging basket in expansion medium (EM, <xref ref-type="sec" rid="s11">Supplementary Table S1</xref> 0.5&#xa0;mL placed in the luminal compartment and 3&#xa0;mL placed in the basal compartment) for 6 days with media exchange every other day (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="B35">Kim et al., 2022</xref>). After a confluent monolayer was formed on day 7, both luminal and basal media were replaced by differentiation medium without antibiotics (DM-Ab, <xref ref-type="sec" rid="s11">Supplementary Table S1</xref> 0.5&#xa0;mL placed in the luminal compartment and 3&#xa0;mL placed in the basal compartment). On day 8, the luminal medium was replaced with 0.5&#xa0;mL 10% peptone-yeast-fructose media (PYF, <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>) in 1&#xd7; PBS.</p>
</sec>
<sec id="s2-3">
<title>2.3 Bacterial culture</title>
<p>
<italic>C. scindens</italic> (ATCC 35704) was purchased from ATCC and propagated within an anaerobic chamber (Coy Laboratory Products). The bacteria were cultured in PYF medium (peptone 10&#xa0;g/L, yeast extract 10&#xa0;g/L, fructose 10&#xa0;g/L, resazurin 1&#xa0;mg/L, L-cysteine hydrochloride 0.5&#xa0;g/L, CaCl<sub>2</sub>&#xb7;H2O 100&#xa0;mg/L, MgSO<sub>4</sub>&#xb7;7H<sub>2</sub>O 50&#xa0;mg/L, K<sub>2</sub>PO<sub>4</sub> 40&#xa0;mg/L, KH<sub>2</sub>PO<sub>4</sub> 40&#xa0;mg/L, NaHCO<sub>3</sub> 0.4&#xa0;g/L, NaCl 80&#xa0;mg/L, hemin (5&#xa0;mg/L) and vitamin K (1&#xa0;mg/L)). <italic>C. scindens</italic> was plated on PYF agar (PYF with 15&#xa0;g/L agar) and cultured anaerobically at 37&#xb0;C using a BD GasPak EZ pouch system (BD, Cat &#x23; 260683). Two days before each experiment a fresh subculture was generated from a single colony for co-culture experiments by culturing in the PYF medium for 48&#xa0;h.</p>
<p>
<italic>S. aureus</italic> strain Newman was kindly provided by Dr. Michelle Reniere at the University of Washington and cultured under aerobic conditions in brain-heart-infusion media (BHI, Research Products International, Cat &#x23;B11000) at 37&#xb0;C. <italic>S. aureus</italic> was plated on BHI agar (BHI with 15&#xa0;g/L agar), and a single colony was used to prepare a bacterial sample after 18&#xa0;h of culture in BHI broth before co-culture experiments.</p>
</sec>
<sec id="s2-4">
<title>2.4 Co-culture experiments</title>
<p>After human colonic epithelial cells fully differentiated in the luminal compartment of the hanging baskets, the luminal medium was substituted with a deoxygenated medium consisting of 10% PYF in 1&#xd7; PBS buffer. This co-culture medium was enriched with 200&#xa0;&#xb5;M cholic acid for bile acid metabolism. Simultaneously, the basal medium was refreshed with fresh DM-Ab media. For <italic>C. scindens</italic> co-culture, 5&#xd7;10<sup>3</sup> colony-forming unit (CFU) in total were added to the luminal media similar to that used previously for other <italic>Clostridioides</italic> (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>). The sealed co-culture or control cultures without bacteria were incubated at 37&#xb0;C for 48&#xa0;h. Due to its rapid growth, a minimal number of <italic>S. aureus</italic> (5 &#xd7; 10<sup>2</sup>&#xa0;CFU in total) was added to specified samples after 24&#xa0;h of co-culture with <italic>C. scindens</italic>. The samples with added <italic>S. aureus</italic> were then incubated at 37&#xb0;C for an additional 24&#xa0;h. The deoxygenated luminal media was 10% PYF in 1 x PBS buffer for both <italic>C. scindens</italic> and <italic>S. aureus</italic>. All inoculations were performed in an anaerobic chamber.</p>
</sec>
<sec id="s2-5">
<title>2.5 Measurement of epithelial cell death</title>
<p>To assess the viability of colonic epithelial cells cultured in the O<sub>2</sub> gradient cassette, DM-Ab medium (3&#xa0;mL) supplemented with 10&#xa0;&#x3bc;g/mL Hoechst 33342 (Thermo Fisher, Cat &#x23;H1399) was added to the basal compartment and then the cells were incubated at 37&#xb0;C for 1&#xa0;h. After washing with PBS, 2&#xa0;&#x3bc;g/mL propidium iodide (PI, Thermo Fisher, Cat &#x23; P3566) in PBS buffer (3&#xa0;mL) was added to the basal compartment, and then incubated at 37&#xb0;C for 20&#xa0;min. Hoechst 33342 was used to label DNA in all epithelial cells, and PI was used to label the DNA of dead epithelial cells. To measure apoptosis, a dead cell apoptosis kit with Annexin V (Thermo Fisher, Cat &#x23;V13242) was used to assess the presence of phosphatidylserine on the plasma membrane of cells. The working solution of the kit contained 1&#xa0;&#x3bc;g/mL Annexin V, 1&#xa0;&#x3bc;g/mL PI, 1.25&#xa0;mM HEPES, 7&#xa0;mM NaCl, 0.05&#xa0;mM EDTA, and 0.005% bovine serum albumin (BSA) in 1&#xd7; binding buffer (10&#xa0;mM HEPES, 140&#xa0;mM NaCl, and 2.5&#xa0;mM CaCl<sub>2</sub>). 500&#xa0;&#x3bc;L of the working solution was used for luminal staining at 25&#xb0;C for 15 min, then the reaction was terminated by mixing with 2&#xa0;mL binding buffer and kept on ice before imaging.</p>
<p>Prior to microscopic imaging, each collagen scaffold with attached cells was carefully cut from the hanging basket, inverted, and placed onto a &#x23;1 coverslip. A confocal fluorescence microscope (Olympus, Fluoview 3,000, Japan) was used to measure the fluorescence of the epithelial cells. The entire epithelial monolayer (approximately 1.1&#xa0;cm<sup>2</sup> surface area) was imaged as a 4 &#xd7; 4 array with a 4&#xd7; (0.16 N.A.) objective. The following fluorescence excitation/emission wavelengths were used- Hoechst 33342: Ex 405&#xa0;nm, Em 430&#x2013;470&#xa0;nm; PI: Ex 561&#xa0;nm, Em 610&#x2013;670&#xa0;nm; Annexin V: Ex 488&#xa0;nm, Em 530&#x2013;575&#xa0;nm. All 16 images of each channel were stitched together to create an image of the entire well.</p>
<p>CellProfiler v4.0 was used to identify and calculate the image area with fluorescence intensity above an empirically set threshold to quantify the area of the epithelial monolayer positive for each of the stains. The processing protocol was modified from a previously reported method (<xref ref-type="bibr" rid="B30">Hinman et al., 2021</xref>). The stitched image at each emission wavelength was flat-field corrected using a Gaussian-smoothed illumination correction function (1000-pixel filter size). The corrected image was converted to binary using 2-class Otsu threshold selection. Then the area of the culture above the fluorescence threshold was calculated. The normalized PI &#x2b; area was calculated as PI &#x2b; area/Hoechst 33342&#x2b; area and was used as a metric for dead cells. The normalized Annexin V&#x2b; area was calculated as Annexin &#x2b; area/Hoechst 33342&#x2b; area and used as a metric for apoptotic cells.</p>
</sec>
<sec id="s2-6">
<title>2.6 Immunofluorescence measurement of the tight junction marker ZO-1</title>
<p>To determine whether tight junctions among the epithelial cells were disrupted in the presence of the bacteria, methanol (4&#xb0;C) was added as a fixative into the luminal compartment, and the sample was placed at &#x2212;20&#xb0;C for 1&#xa0;h. The fixed cells were then washed in PBS and blocked with 3% BSA in PBS for 1&#xa0;h at 25&#xb0;C. Next, 200&#xa0;&#xb5;L ZO-1 primary antibody (2&#xa0;&#x3bc;g/mL, Proteintech, Cat &#x23;21773-1-AP, RRID:AB_10733242) was added to the luminal compartment and incubated with the cells at 4&#xb0;C for 18&#xa0;h. The sample was then washed 3 times with IF wash buffer (0.1% BSA, 0.2% Triton-X 100, 0.05% Tween 20 in 1&#xd7; PBS) and then incubated with 500&#xa0;&#xb5;L secondary antibody conjugated with Alexa Fluor 647 (1&#xa0;&#x3bc;g/mL, Thermo Fisher Scientific, Cat &#x23;A27040, RRID:AB_2536101) containing 10&#xa0;&#x3bc;g/mL Hoechst 33342 for 1&#xa0;h at 25&#xb0;C. The sample was then washed twice with PBS buffer. Prior to confocal microscopy, each collagen scaffold with attached cells was carefully cut from the hanging basket, inverted, and placed on a &#x23;1 coverslip. Fluorescence was then quantified using a 30&#xd7; objective oil lens (1.05 N.A.). Fluorescence was measured using the following parameters- ZO-1: Ex 640&#xa0;nm, Em 650&#x2013;750&#xa0;nm; Hoechst: Ex 405&#xa0;nm, Em 430&#x2013;470&#xa0;nm. Five different locations (top, bottom, right, left, center) of each sample were imaged. The images were processed and analyzed within CellProfiler v4.0 following a previous protocol (<xref ref-type="bibr" rid="B30">Hinman et al., 2021</xref>).</p>
</sec>
<sec id="s2-7">
<title>2.7 Measurement of bacterial cells</title>
<p>The luminal contents (media &#x2b; collagen scaffold) were collected and mixed in a tube with 3&#xa0;mL 500 U/mL collagenase in PBS, followed by 30&#xa0;min incubation at 25&#xb0;C under anaerobic conditions. Next, the suspension was vortexed for 2 min, and then plated on PYF (for <italic>C. scindens</italic>) or BHI (for <italic>S. aureus</italic>) agar. The CFU on the agar plates after 24&#x2013;48&#xa0;h incubation anaerobically (for <italic>C. scindens</italic>) or aerobically (for <italic>S. aureus</italic>) was counted and used as a measure of the viability of the bacterial cells.</p>
<p>To visualize the bacterial cells while still present on the epithelial monolayer, 200&#xa0;&#xb5;L 1&#xa0;&#x3bc;M SYTO 9 (Thermo Fisher, Cat &#x23;S34854) in PBS was added to the luminal compartment for 20&#xa0;min. Epithelial cells were visualized by addition of Hoechst 33342 (10&#xa0;&#x3bc;g/mL, PBS) followed by incubation for 1&#xa0;h. The collagen scaffold with attached cells was carefully cut from the hanging basket, inverted, and placed on a &#x23;1 coverslip. Both bacterial and epithelial cells were imaged by confocal fluorescence microscopy using a 60&#xd7; oil objective lens (1.3 N.A.) under the following parameters- Hoechst 33342: Ex 405&#xa0;nm, Em 430&#x2013;470&#xa0;nm; SYTO9: Ex 488&#xa0;nm, Em 500&#x2013;520&#xa0;nm.</p>
</sec>
<sec id="s2-8">
<title>2.8 ELISA assays of secreted cytokines</title>
<p>The IL-8 concentration in the basal media was measured using an interleukin 8 (IL-8) ELISA kit (Thermo Fisher Scientific, Cat &#x23;88-8086-22) following the manufacturer&#x2019;s protocol. The basal media were diluted at 1:10 (control) or 1:20 (co-culture) so that the measured signals fit in the range of the standard curve provided with the kit. The MCP-1 concentration in the basal media was measured using a monocyte chemoattractant protein-1 (MCP-1) ELISA kit (Thermo Fisher Scientific, Cat &#x23;88&#x2013;7399-88) following the manufacturer&#x2019;s protocol.</p>
</sec>
<sec id="s2-9">
<title>2.9 Measurement of bile acid in epithelial-<italic>Clostridium scindens</italic> co-culture</title>
<p>After 48&#xa0;h of co-culture in the presence of bile acid, both the luminal contents (media &#x2b; collagen matrix) and basal media were collected separately. The luminal contents were degraded by collagenase as described above and the supernatant collected after centrifugation (10 min, 3,000&#xd7;G). The luminal supernatant and basal media were assayed for bile acids by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis as described previously (<xref ref-type="bibr" rid="B24">Ginos et al., 2018</xref>; <xref ref-type="bibr" rid="B48">Navarro et al., 2020</xref>) at the University of Washington Mitochondria and Metabolism Center.</p>
<p>As a control, cholic or deoxycholic acid was added to <italic>S. aureus</italic> cultured in 96-well plates. Diluted <italic>S. aureus</italic> (1/10<sup>6</sup>) was added to wells containing 200&#xa0;&#xb5;L 10% PYF (in 1&#xd7; PBS) medium supplemented by 25&#x2013;200&#xa0;&#xb5;M cholic acid or deoxycholic acid and incubated anaerobically. After 24&#xa0;h at 37&#xb0;C, the optical density (O.D.) at 600&#xa0;nm of the medium in each well was measured.</p>
</sec>
<sec id="s2-10">
<title>2.10 Measurement of total enterotoxin produced by <italic>Staphylococcus aureus</italic>
</title>
<p>The luminal contents (media &#x2b; collagen scaffold) were collected and mixed with collagenase as described above. The supernatant was collected after centrifugation. The concentration of <italic>S. aureus</italic> enterotoxin in the supernatant was measured using a sandwich enzyme immunoassay kit (RIDASCREEN<sup>&#xae;</sup> SET Total, R-Biopharm AG, German) following the manufacturer&#x2019;s protocol. The O.D. of each sample was measured and an O.D. of 0.15 greater than that of the negative control value was set as a threshold for a positive sample. The concentration of enterotoxin was represented as relative O.D., <italic>i.e.</italic>, normalized to the positive control mean (set equal to 100%).</p>
</sec>
<sec id="s2-11">
<title>2.11 Statistical analyses</title>
<p>Origin 9 was used for statistical analyses of the data. All <italic>p</italic> values were calculated by ordinary one-way ANOVA. A significance level of 0.05 was used, and any <italic>p</italic>-value below this threshold was considered statistically significant. (&#x2a;: <italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;: <italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;: <italic>p</italic> &#x3c; 0.001). In this manuscript, we define a &#x201c;technical replicate&#x201d; as being separate experiments on different days but using the cells of a single donor.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Experimental overview and design</title>
<p>
<italic>C. scindens</italic> is a bacterium often found in the human colon (<xref ref-type="bibr" rid="B79">White et al., 1980</xref>; <xref ref-type="bibr" rid="B46">MORRIS et al., 1985</xref>). <italic>C. scindens</italic> is remarkable for its 7-dehydroxylation activity that transforms primary bile acids (<italic>e.g.</italic>, cholic acid) to secondary bile acids (deoxycholic acid and lithocholic acid). Secondary bile acids are reported to inhibit the growth of intestinal pathogens, such as <italic>S. aureus</italic>, supporting a role for <italic>C. scindens</italic> as a probiotic species enhancing resistance to gastrointestinal infection (<xref ref-type="bibr" rid="B6">Buffie et al., 2015</xref>). <italic>S. aureus</italic> is a common cause of gastrointestinal illness after consumption of <italic>S. aureus</italic>-contaminated food (<xref ref-type="bibr" rid="B7">CDC, 2018</xref>). The toxicity of <italic>S. aureus</italic> is derived from enterotoxins that increase the permeability of the epithelial barrier and initiate epithelial cell death (<xref ref-type="bibr" rid="B45">Moret&#xf3; and P&#xe9;rez-Bosque, 2009</xref>; <xref ref-type="bibr" rid="B71">&#x160;uligoj et al., 2020</xref>). The overall goal of this study was to co-culture these two bacterial species with primary human gastrointestinal epithelial cells to demonstrate the utility of multi-species gut-on-chip models for intestinal microbiota research and the study of the interactions between the microbiome and human host.</p>
<p>
<italic>Clostridial</italic> species such as <italic>C. scindens</italic> tolerate O<sub>2</sub> concentrations up to 2%&#x2013;3% (<xref ref-type="bibr" rid="B47">Morvan et al., 2021</xref>; <xref ref-type="bibr" rid="B10">Chia, 2023</xref>), but higher concentrations are lethal. These obligate anaerobes are able to survive in the environment of the luminal-facing differentiated colonic epithelium that exists in physiologic hypoxia of &#x3c;1&#x2013;3% O<sub>2</sub>. In contrast, the O<sub>2</sub> concentration increases to 10% near the colonic epithelial cells at the crypt base, <italic>i.e.</italic>, deeper in the submucosa, where the stem-cell niche produces proliferative cells to replenish the epithelial layer (<xref ref-type="bibr" rid="B32">Keeley and Mann, 2019</xref>; <xref ref-type="bibr" rid="B64">Schwerdtfeger et al., 2019</xref>). To achieve these distinct O<sub>2</sub> conditions, a modified cell culture cassette for O<sub>2</sub>-gradient formation was previously demonstrated for co-culture of epithelial cells and anaerobes (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="B35">Kim et al., 2022</xref>). This cassette, based on a hanging basket, possessed luminal and basal reservoirs so that both sides of the colonic epithelial cell culture were accessible. To create an O<sub>2</sub> gradient across the tissue surface, the side walls of the luminal compartment were impervious to O<sub>2</sub> and an O<sub>2</sub> impermeable plug was inserted into the luminal reservoir to prevent atmospheric O<sub>2</sub> ingress. In contrast, the basal reservoir was open to the environment. Under these conditions, a confluent monolayer of epithelial cells has been shown to consume O<sub>2</sub> at a sufficient rate to decrease the luminal O<sub>2</sub> to &#x3c;1% in 3.75&#xa0;h (<xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>). In the current experiments, epithelial stem cells were plated on the luminal side of the hanging basket&#x2019;s porous membrane in the cassette and cultured in a medium rich in growth factors (expansion medium, EM) without the luminal plug so that a high O<sub>2</sub> tension was maintained (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). After forming a confluent monolayer, the cells were fully differentiated by removal of growth factors (differentiation medium without antibiotics, DM -Ab) producing a high-resistance epithelial monolayer (TEER &#x3d; 507 &#xb1; 126&#xa0;&#x2126;&#xb7;cm<sup>2</sup>, n &#x3d; 3, <xref ref-type="fig" rid="F1">Figure 1C</xref>). The luminal DM -Ab was then replaced with a minimal nutrient medium (PYF) suitable for bacterial culture (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The cassette was then transferred into an anaerobic chamber (<xref ref-type="fig" rid="F1">Figure 1E</xref>), the plug was installed, and the assembled cassette was placed in a standard tissue-culture incubator (<xref ref-type="fig" rid="F1">Figure 1F</xref>). Under these conditions, the maximal O<sub>2</sub> concentration in the luminal compartment was 0.6% &#xb1; 0.4% after plug installation and decreased to a steady state value of 0.4% &#xb1; 0.1% during culture due to continued O<sub>2</sub> consumption by the epithelial cells (<xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>). <italic>C. scindens</italic> was subsequently inoculated onto the intestinal epithelium at 10<sup>3</sup> colony-forming unit (CFU)/ml (1,300 &#xb1; 500 cells in total). The CFU increased to 3&#xd7;10<sup>4</sup> &#xb1; 0.95 &#xd7; 10<sup>4</sup>&#xa0;CFU/mL (approximately 15,500 &#xb1; 5,000 in total, doubling time 13&#xa0;h) after 48&#xa0;h (<italic>p</italic> &#x3d; 0.045, <xref ref-type="sec" rid="s11">Supplementary Figure S3A</xref>), suggesting that <italic>C. scindens</italic> not only tolerated the luminal microenvironment but was able to replicate.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic of co-culture of primary human colonic epithelial cells with bacteria. EM is a medium rich in growth factors to support stem cell expansion (green cells with blue nuclei), while DM -Ab is an antibiotic-free medium without stem-cell supportive growth factors to support the formation of differentiated cells (red cells with blue nuclei). PYF supports the growth of bacteria (green rods). The fluorescence micrograph (far lower left) shows the co-culture of differentiated colonic epithelial cells (Hoechst 33342-stained nuclei in blue) and <italic>C. scindens</italic> (green rods). The scale bar represents 10&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fbioe-12-1382389-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Co-culture of epithelial cells with <italic>Clostridium scindens</italic>
</title>
<p>The <italic>in vivo</italic> colonic lumen acts as a host to <italic>C. scindens</italic> with co-existence of and mutual benefit for both the mammalian and bacterial cells. <italic>C. scindens</italic> ferments fiber and metabolizes bile acids to support both the health of the microbial community as well as that of the epithelial cells (<xref ref-type="bibr" rid="B81">Wlodarska et al., 2017</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>). In turn the epithelial cells form a tight barrier to prevent the intrusion of bacteria into the tissue and collaborate with the immune system to repel invading microbes (<xref ref-type="bibr" rid="B8">Chen et al., 2021</xref>). To determine whether the epithelial cells might be able to co-exist with the obligate anaerobes in the absence of an immune system, <italic>C. scindens</italic> was cultured on a confluent, differentiated epithelial cell layer. The impact on epithelial cell viability and monolayer barrier function was then assessed. When stained with propidium iodide (PI), no significant difference in epithelial cell death was observed in the presence and absence of <italic>C. scindens</italic> (9.8% &#xb1; 7.5% PI &#x2b; area normalized to total Hoechst 33342&#x2b; cell area for the control vs. 10.8% &#xb1; 4.2% after 48&#xa0;h of co-culture with <italic>C. scindens</italic>, <italic>p</italic> &#x3d; 0.64, <xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S4A</xref>). Programmed cell death was assessed using an annexin V conjugate assay to identify phosphatidylserine in the outer membrane leaflet. No significant difference in the binding of annexin V to the epithelial cells was observed in the absence and presence of <italic>C. scindens</italic> (9.5% &#xb1; 4.0% annexin V&#x2b; area normalized to total Hoechst 33342&#x2b; cell area for the control vs. 6.1% &#xb1; 1.6% after 48&#xa0;h of co-culture with <italic>C. scindens</italic>, <italic>p</italic> &#x3d; 0.24, <xref ref-type="fig" rid="F2">Figure 2B</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S4B</xref>). Barrier integrity was measured by assaying the TEER after 48&#xa0;h of culture with and without <italic>C. scindens</italic>. In both instances the TEER decreased over time but was not significantly different (control 168 &#xb1; 18 vs. 150 &#xb1; 37&#xa0;&#x2126;&#xb7;cm<sup>2</sup> with <italic>C. scindens</italic>, <italic>p</italic> &#x3d; 0.45, <xref ref-type="sec" rid="s11">Supplementary Figure S5A</xref>). Since TEER represents a global measurement of barrier function, the integrity of cell-cell junctions was also assessed by fluorescent staining for ZO-1, which is a constituent of tight junctions located on the cytoplasmic membrane surface (<xref ref-type="bibr" rid="B43">McNeil et al., 2006</xref>). When visualized by microscopy, cells with and without <italic>C. scindens</italic> co-cultured for 48&#xa0;h possessed similar ZO-1 staining patterns (<xref ref-type="fig" rid="F2">Figure 2C</xref>). When the area, circularity, and perimeter of the cells was measured, no significant differences were identified for the epithelial cells with and without <italic>C. scindens</italic> (area: 77 &#xb1; 19&#xa0;&#x3bc;m<sup>2</sup> without vs. 70 &#xb1; 15&#xa0;&#x3bc;m<sup>2</sup> with, <italic>p</italic> &#x3d; 0.3; circularity: 0.78 &#xb1; 0.02 without vs. 0.79 &#xb1; 0.02 with, <italic>p</italic> &#x3d; 0.2; perimeter: 34 &#xb1; 5&#xa0;&#xb5;m without vs. 32 &#xb1; 4&#xa0;&#xb5;m with, <italic>p</italic> &#x3d; 0.3, N &#x3d; 3 technical replicates, <xref ref-type="sec" rid="s11">Supplementary Figure S6</xref>). These data suggest that although the number of <italic>C. scindens</italic> expanded 10-fold, the epithelial cells did not die or lose barrier integrity during the 48&#xa0;h of co-culture. However, extremely high numbers of inoculated <italic>C. scindens</italic> (&#x223c;5&#xd7;10<sup>6</sup> cells) did result in an increase in epithelial cell death at 48&#xa0;h of co-culture (<xref ref-type="sec" rid="s11">Supplementary Figure S7</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Co-culture of primary human colonic epithelial cells with <italic>C. scindens</italic>. <bold>(A, B)</bold> Fluorescence images of colonic epithelial cells stained with PI (red, panel <bold>(A)</bold>, annexin V (yellow, panel <bold>(B)</bold>, and Hoechst 33342 (blue) with and without <italic>C. scindens</italic> co-culture for 48&#xa0;h. Scale bar &#x3d; 50&#xa0;&#xb5;m with the inset scale bar &#x3d; 10&#xa0;&#xb5;m. <bold>(C)</bold> Images of colonic epithelial cells stained for ZO-1 (magenta). Scale bar &#x3d; 50&#xa0;&#xb5;m with the inset scale bar &#x3d; 10&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fbioe-12-1382389-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Measurement of epithelial cell inflammation in the presence of <italic>Clostridium scindens</italic>
</title>
<p>IL-8 and MCP-1 are chemokines produced by epithelial cells in response to bacterial products and are often used as markers of an epithelial cell inflammatory response (<xref ref-type="bibr" rid="B16">Deshmane et al., 2009</xref>; <xref ref-type="bibr" rid="B38">La Pine and Hill, 2011</xref>). The concentrations of IL-8 and MCP-1 in the basal media were measured in the absence and presence of <italic>C. scindens</italic> co-culture after 48&#xa0;h. The concentration of IL-8 was not significantly different in the two culture conditions (687 &#xb1; 149&#xa0;pg/mL without vs. 789 &#xb1; 199&#xa0;pg/mL with <italic>C. scindens</italic>, <italic>p</italic> &#x3d; 0.38, <xref ref-type="sec" rid="s11">Supplementary Figure S8A</xref>). Likewise, the concentration of MCP-1 was not significantly different (9.8 &#xb1; 2.1&#xa0;pg/mL without vs. 7.4 &#xb1; 1.8&#xa0;pg/mL with <italic>C. scindens</italic>, <italic>p</italic> &#x3d; 0.21, <xref ref-type="sec" rid="s11">Supplementary Figure S8B</xref>). The concentration of IL-8 secreted into the basal reservoir was similar to that in previous studies (300&#x2013;600&#xa0;pg/mL) (<xref ref-type="bibr" rid="B77">Wang et al., 2018b</xref>; <xref ref-type="bibr" rid="B35">Kim et al., 2022</xref>). Additionally, the concentration of MCP-1 was near that reported for colonic epithelial cell cultures (6.9&#x2013;27&#xa0;pg/mL) (<xref ref-type="bibr" rid="B23">Futagami et al., 2003</xref>; <xref ref-type="bibr" rid="B21">Fujita et al., 2010</xref>). Under these conditions, the co-culture of <italic>C. scindens</italic> did not alter the inflammatory response of the colonic cells.</p>
</sec>
<sec id="s3-4">
<title>3.4 Metabolism of cholic acid by <italic>Clostridium scindens</italic>
</title>
<p>Bile acids flow from the liver into the small intestine via the bile duct. The major portion of bile acids (&#x223c;80%) are actively transported back to liver in the terminal ileum. However, &#x223c;15% of bile acids transit through the digestive tract to reach the colon and are then metabolized by bacteria into secondary bile acids that diffuse passively across the colonic epithelium to return to the liver (<xref ref-type="bibr" rid="B17">Di Ciaula et al., 2017</xref>). <italic>C. scindens</italic> is known to convert primary bile acids such as cholic acid into a variety of secondary bile acids (<italic>e.g.</italic>, deoxycholic acid and lithocholic acid) in the colon (<xref ref-type="bibr" rid="B79">White et al., 1980</xref>; <xref ref-type="bibr" rid="B57">Ridlon et al., 2014</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>). To assess bile acid conversion by <italic>C. scindens</italic>, cholic acid (200&#xa0;&#xb5;M) was added in the luminal reservoir in the presence of epithelial cells with or without <italic>C. scindens</italic> and the concentrations of cholic acid and its metabolites were measured by mass spectrometry (<xref ref-type="fig" rid="F3">Figure 3</xref>). In the absence of <italic>C. scindens</italic>, only cholic acid (99.37% of total luminal bile acids) was found in the luminal reservoir. In these cultures, cholic acid was also detected in the basal compartment (98.06% of total basal bile acids). In contrast, the luminal reservoir of epithelial cells co-cultured with <italic>C. scindens</italic> demonstrated a range of secondary bile acids (&#x3e;99% conversion) with the predominant being apocholic acid (58.33% of total luminal bile acids), which is a byproduct of the dehydration of cholic acid (<xref ref-type="bibr" rid="B65">Shi et al., 2023</xref>). Other prominent metabolites identified in the luminal compartment included 3&#x3b1;-hydroxy-12 ketolithocholic acid (21.96% of total luminal bile acids) and deoxycholic acid (11.84% of total luminal bile acids). These two metabolites are formed via a dehydroxylation pathway of <italic>C. scindens</italic> and have been observed previously <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B40">Marion et al., 2019</xref>; <xref ref-type="bibr" rid="B22">Funabashi et al., 2020</xref>). The basal compartment possessed a distinct pattern of bile acids. The predominant secondary bile acid was deoxycholic acid (50.49% of total basal bile acids) in the presence of <italic>C. scindens</italic>, but untransformed cholic acid was also present (41.61% of total basal bile acids) as were other products. The presence of the bile acids in the basal compartment was most likely due to passive diffusion as occurs in the colon <italic>in vivo</italic> (<xref ref-type="bibr" rid="B44">Mekhjian et al., 1979</xref>). These data suggest that molecular interactions between <italic>C. scindens</italic>-epithelial cells, such as bile acid metabolism were present in this <italic>in vitro</italic> system.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Formation of cholic acid metabolites. Cholic acid was added to the luminal compartment of the hanging basket with cultured epithelial cells in the absence and presence of <italic>C. scindens</italic>. The metabolites were measured in the luminal and basal compartments of the cassette by mass spectrometry.</p>
</caption>
<graphic xlink:href="fbioe-12-1382389-g003.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Co-culture of colonic epithelial cells with the intestinal pathogen <italic>Staphylococcus aureus</italic>
</title>
<p>
<italic>S. aureus</italic> is a facultative anaerobe normally found on human skin and within the nasal cavities but can be an opportunistic pathogen of the colon (<xref ref-type="bibr" rid="B51">O&#x27;Gara, 2017</xref>). <italic>S. aureus</italic> is able to produce a range of toxins including enterotoxins (SEs), hemolysins, and leukotoxins (<xref ref-type="bibr" rid="B36">Kong et al., 2016</xref>) so that colonization of the colon by <italic>S. aureus</italic> can lead to severe nausea, vomiting, and diarrhea (<xref ref-type="bibr" rid="B7">CDC, 2018</xref>). To examine the cytotoxicity of <italic>S. aureus</italic> to colonic epithelial cells, we inoculated <italic>S. aureus</italic> onto the epithelial monolayer at 900 &#xb1; 370&#xa0;CFU/mL (450 &#xb1; 190 cells in total). After 24&#xa0;h of co-culture in the anaerobic cassette, <italic>S. aureus</italic> numbers increased to 1.4&#xd7;10<sup>8</sup> &#xb1; 6 &#xd7; 10<sup>7</sup>&#xa0;CFU/mL (7.0&#xd7;10<sup>7</sup> &#xb1; 2.8&#xd7;10<sup>7</sup> total cells), which was significantly higher than the initial inoculum (<italic>p</italic> &#x3d; 0.02, <xref ref-type="fig" rid="F4">Figure 4A</xref>; <xref ref-type="sec" rid="s11">Supplementary Figure S3B</xref>) and represents a doubling time of &#x223c;83&#xa0;min. Growth of <italic>S. aureus</italic> on the epithelial cell culture was substantially more robust than that of <italic>C. scindens</italic> (<xref ref-type="bibr" rid="B45">Moret&#xf3; and P&#xe9;rez-Bosque, 2009</xref>; <xref ref-type="bibr" rid="B42">Martens et al., 2021</xref>). As the epithelial cells died as a result of co-culture with <italic>S. aureus</italic>, many nutrients may have become available to benefit the growth of <italic>S. aureus</italic>. In these co-cultures, <italic>S. aureus</italic> grew both in a dispersed manner as well as in clusters or sheets of bacteria fully covering the monolayer, suggesting the formation of biofilms.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Co-culture of colonic epithelial cells with <italic>Staphylococcus aureus</italic>. <bold>(A)</bold> Fluorescence images of epithelial cell co-culture with <italic>S. aureus</italic> after 1&#xa0;d. Colonic epithelial cell nuclei were stained with Hoechst 33342 (blue), and <italic>S. aureus</italic> was stained with SYTO9 (green). Scale bar &#x3d; 10&#xa0;&#xb5;m and the inset scale bar is 2&#xa0;&#xb5;m. <bold>(B)</bold> Images of colonic epithelial cells stained with PI (red) and Hoechst 33342 (blue) cultured with and without <italic>S. aureus</italic> for 1&#xa0;d. Scale bar &#x3d; 50&#xa0;&#xb5;m and the inset scale bar &#x3d; 10&#xa0;&#xb5;m. <bold>(C)</bold> Images of colonic epithelial cells stained with ZO-1 (magenta) when cultured with and without <italic>S. aureus</italic>. Scale bar &#x3d; 50&#xa0;&#xb5;m and the inset scale bar &#x3d; 10&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fbioe-12-1382389-g004.tif"/>
</fig>
<p>The impact of <italic>S. aureus</italic> on the epithelial cells was assessed by measuring epithelial cell death and monolayer barrier integrity. Compared to control cultures, the viability of colonic epithelial cells in the presence of <italic>S. aureus</italic> was significantly decreased after 24&#xa0;h of co-culture (9.8% &#xb1; 7.5% PI &#x2b; area normalized to total Hoechst 33342&#x2b; cell area for the control vs. 68% &#xb1; 16% after co-culture with <italic>S. aureus</italic>, <italic>p</italic> &#x3d; 0.0007, <xref ref-type="fig" rid="F5">Figure 5E</xref>). Visually, a majority of the epithelial cells appeared dead in the cultures (<xref ref-type="fig" rid="F4">Figure 4B</xref>). This is consistent with the measured TEER of 70 &#xb1; 12&#xa0;&#x2126;&#xb7;cm<sup>2</sup> (<italic>p</italic> &#x3c; 0.001 relative to control, <xref ref-type="sec" rid="s11">Supplementary Figure S5B</xref>), indicating a complete loss of barrier function in the presence of <italic>S. aureus</italic> after 24&#xa0;h. To examine cell-cell tight junctions, the epithelial monolayers were stained for ZO-1, which showed a loss of cell boundaries and an appearance of large aggregates of ZO-1 in the colonic cells. This finding indicated that the intercellular tight junctions were disrupted in these cultures (<xref ref-type="fig" rid="F4">Figure 4C</xref>). Further confirmation was obtained by quantification of the epithelial cells&#x2019; morphology with the area, perimeter, and circularity all significantly different compared to that of colonic cells cultured in the absence of <italic>S. aureus</italic> (area: 77 &#xb1; 19&#xa0;&#x3bc;m<sup>2</sup> without vs. 161 &#xb1; 43&#xa0;&#x3bc;m<sup>2</sup> with, <italic>p</italic> &#x3c; 0.001; circularity: 0.78 &#xb1; 0.02 without vs. 0.69 &#xb1; 0.04 with, <italic>p</italic> &#x3c; 0.001; perimeter: 34 &#xb1; 5&#xa0;&#xb5;m without vs. 54 &#xb1; 7&#xa0;&#xb5;m with, <italic>p</italic> &#x3c; 0.001, N &#x3d; 3 technical replicates, <xref ref-type="sec" rid="s11">Supplementary Figure S6</xref>). The area and perimeter of the epithelial cells increased in the presence of <italic>S. aureus</italic> while the circularity decreased, in agreement with the observed distorted cell boundaries on the micrographs. Consistent with these results, the IL-8 concentration in the basal compartment of the epithelial cells was significantly increased after 24&#xa0;h of <italic>S. aureus</italic> co-culture compared to that for the epithelial cells alone (531 &#xb1; 196&#xa0;pg/mL vs. 1,382 &#xb1; 329&#xa0;pg/mL, <italic>p</italic> &#x3d; 0.02, <xref ref-type="fig" rid="F5">Figure 5F</xref>). It is noteworthy that <italic>S. aureus</italic> was inoculated onto the epithelial monolayer at a 2-to-3-fold lower CFU than <italic>C. scindens</italic>. The shorter <italic>S. aureus</italic> doubling time and potentially toxin production under these conditions enabled <italic>S. aureus</italic> to expand in number rapidly, leading to a cellular inflammatory response, cell death, and destruction of the monolayer barrier integrity.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Co-culture of colonic epithelial cells with <italic>C. scindens</italic> and <italic>S. aureus</italic>. <bold>(A)</bold> Images of the co-culture. The nuclei of colonic epithelial cells were stained with Hoechst 33342 (blue), and <italic>S. aureus</italic> and <italic>C. scindens</italic> were stained with SYTO9 (green). Scale bar &#x3d; 10&#xa0;&#xb5;m and the inset scale bar &#x3d; 5&#xa0;&#xb5;m. <bold>(B&#x2013;D)</bold> Images of colonic epithelial cells stained with PI (red) and Hoechst 33342 (blue) co-cultured with <italic>S. aureus</italic> &#x2b; <italic>C. scindens</italic> <bold>(B)</bold>, <italic>S. aureus</italic> &#x2b; 200&#xa0;&#xb5;M cholic acid <bold>(C)</bold>, and <italic>S. aureus</italic> &#x2b; <italic>C. scindens</italic> &#x2b; 200&#xa0;&#xb5;M cholic acid <bold>(D)</bold>, scale bar &#x3d; 50&#xa0;&#xb5;m and the inset scale bar &#x3d; 10&#xa0;&#xb5;m. <bold>(E)</bold> Measurement of dead cells in the absence and presence of <italic>C. scindens</italic>, <italic>S. aureus</italic>, and/or cholic acid. The Y-axis is the PI-positive area normalized to the Hoechst 33342-positive area, N &#x3d; 6 technical replicates. <bold>(F)</bold> The IL-8 concentration was measured in the basal media before (open bars) and after (closed bars) co-culturing with <italic>S. aureus</italic>, <italic>C. scindens</italic>, and/or cholic acid (200&#xa0;mM). N &#x3d; 3 technical replicates.</p>
</caption>
<graphic xlink:href="fbioe-12-1382389-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 Co-culture of epithelial cells with <italic>Clostridium scindens</italic> and <italic>Staphylococcus aureus</italic>
</title>
<p>As a commensal strain, <italic>C. scindens</italic> exerts a protective effect on the colon by converting 7&#x3b1;-dehydroxylating primary bile acids to form secondary bile acids which then inhibit pathogenic bacterial growth (<xref ref-type="bibr" rid="B25">Greathouse et al., 2015</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>). To explore this defensive behavior of <italic>C. scindens</italic>, epithelial monolayers were colonized with <italic>C. scindens</italic> by co-culture for 24&#xa0;h. <italic>S. aureus</italic> was then inoculated onto the <italic>C. scindens</italic>/epithelial cell co-culture (<xref ref-type="fig" rid="F5">Figure 5A</xref>). After an additional 24&#xa0;h of incubation, epithelial cell death, cell morphology, and secreted cytokines were measured. Pre-culture of the epithelial cells with <italic>C. scindens</italic> significantly enhanced the viability of the epithelial cells after addition of <italic>S. aureus</italic> (<italic>p</italic> &#x3d; 0.02, <xref ref-type="fig" rid="F5">Figures 5B,E</xref>). Remarkably, epithelial cell death in the presence of both <italic>C. scindens</italic> and <italic>S. aureus</italic> was not significantly different from epithelial cells in the absence of bacteria (<italic>p</italic> &#x3d; 0.18, <xref ref-type="fig" rid="F5">Figure 5E</xref>). Furthermore when ZO-1 immunofluorescence was measured, the presence of pre-cultured <italic>C. scindens</italic> also reduced the alterations in cell morphology in the co-culture with <italic>S. aureus</italic> compared to culture in the absence of <italic>C. scindens</italic> (area: 161 &#xb1; 43&#xa0;&#x3bc;m<sup>2</sup> with <italic>S. aureus</italic> only vs. 116 &#xb1; 30&#xa0;&#x3bc;m<sup>2</sup> with both, <italic>p</italic> &#x3d; 0.01; circularity: 0.69 &#xb1; 0.04 with <italic>S. aureus</italic> only vs. 0.74 &#xb1; 0.03 with both, <italic>p</italic> &#x3d; 0.003; perimeter: 54 &#xb1; 7&#xa0;&#xb5;m with <italic>S. aureus</italic> only vs. 43 &#xb1; 7&#xa0;&#xb5;m with both, <italic>p</italic> &#x3d; 0.008, N &#x3d; 3 technical replicates, <xref ref-type="sec" rid="s11">Supplementary Figures S6, S10</xref>). The presence of <italic>C. scindens</italic>, however, did not significantly alter the amount of IL-8 secreted in the presence of <italic>S. aureus</italic> alone (<italic>p</italic> &#x3d; 0.8, <xref ref-type="fig" rid="F5">Figure 5F</xref>) suggesting that the epithelium was still inflamed by the presence of the <italic>S. aureus</italic>, but protected from death by the co-culture with <italic>C. scindens</italic>. The measured <italic>S. aureus</italic> CFU in the absence or presence of <italic>C. scindens</italic> was not significantly different (7.0&#xd7;10<sup>7</sup> &#xb1; 2.8&#xd7;10<sup>7</sup> without vs. 6.3&#xd7;10<sup>7</sup> &#xb1; 2.4&#xd7;10<sup>7</sup> with <italic>C. scindens</italic>, <italic>p</italic> &#x3d; 0.83, <xref ref-type="sec" rid="s11">Supplementary Figure S3B</xref>), therefore repression of <italic>S. aureus</italic> growth was not an explanation for the increased epithelial cell survival, which was affirmed when the two bacteria were co-cultured in the absence of an epithelium (<xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>).</p>
<p>Secondary bile acids are reported to diminish the negative impact of <italic>S. aureus</italic> by disruption of the bacterium&#x2019;s membrane (<xref ref-type="bibr" rid="B62">Sannasiddappa et al., 2017</xref>), and by minimizing excessive inflammation through inhibition of NF-&#x3ba;B and NLRP3 pathways (<xref ref-type="bibr" rid="B86">Zhao et al., 2023</xref>). Cholic acid (200&#xa0;&#xb5;M) was added to the luminal compartment during <italic>C. scindens</italic> colonization to enable the formation of secondary bile metabolites. <italic>S. aureus</italic> was then added, and epithelial cell death and IL-8 secretion were measured after 24&#xa0;h. Epithelial cell death was not significantly decreased by the addition of cholic acid to the <italic>C. scindens-S. aureus</italic> mixed culture (<italic>p</italic> &#x3d; 0.13, <xref ref-type="fig" rid="F5">Figure 5B,D,E</xref>). IL-8 production was also not significantly altered in the presence of cholic acid relative to that without cholic acid (<italic>p</italic> &#x3d; 0.92, <xref ref-type="fig" rid="F5">Figure 5F</xref>). Cholic acid added to epithelial monolayers with only <italic>S. aureus</italic> (no <italic>C. scindens</italic>) did not significantly alter epithelial cell viability (<italic>p</italic> &#x3d; 0.88) or IL-8 production (<italic>p</italic> &#x3d; 0.46) compared to <italic>S. aureus</italic> only co-cultures (<xref ref-type="fig" rid="F5">Figure 5C,E,F</xref>). The measured <italic>S. aureus</italic> CFU in the absence or presence of <italic>C. scindens</italic> &#x2b; cholic acid was not significantly different (7.0&#xd7;10<sup>7</sup> &#xb1; 2.8&#xd7;10<sup>7</sup> without vs. 6.6&#xd7;10<sup>7</sup> &#xb1; 3.8&#xd7;10<sup>7</sup> with <italic>C. scindens</italic>/cholic acid, <italic>p</italic> &#x3d; 0.93, <xref ref-type="sec" rid="s11">Supplementary Figure S3B</xref>), so repression of <italic>S. aureus</italic> growth was again not a likely explanation for the improved epithelial cell survival. These results depart from the findings of prior studies in which bile acids repressed the growth of <italic>S. aureus</italic> (<xref ref-type="bibr" rid="B62">Sannasiddappa et al., 2017</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>); however, we note that epithelial cells were absent from those experiments. For this reason, we cultured <italic>S. aureus</italic> in the presence of cholic acid and deoxycholic acid but without epithelial cells. We observed a significantly decreased growth rate as measured by O.D. (<xref ref-type="sec" rid="s11">Supplementary Figure S9</xref>). It is likely that the epithelial cells, <italic>C. scindens</italic>, or their metabolic products other than bile acids are acting in a complex manner to impact <italic>S. aureus</italic> growth.</p>
</sec>
<sec id="s3-7">
<title>3.7 Measurement of <italic>Staphylococcus aureus</italic> toxin in the presence of <italic>Clostridium scindens</italic> and epithelial cells</title>
<p>
<italic>S. aureus</italic> enterotoxins (SEs) are potent exotoxins that damage colonic epithelial cells by stimulating the secretion of cytokines and provoking inflammation (<xref ref-type="bibr" rid="B2">Aljasir and D&#x2019;Amico, 2020</xref>; <xref ref-type="bibr" rid="B14">Cretenet et al., 2011</xref>). Enterotoxin B (SEB) also disrupts the integrity of epithelial barriers, initiating cell death (<xref ref-type="bibr" rid="B42">Martens et al., 2021</xref>). To determine whether <italic>C. scindens</italic> reduces the cytotoxicity of <italic>S. aureus</italic> by altering toxin formation, enterotoxin (SE) production by <italic>S. aureus</italic> was measured in the luminal reservoir. For simplicity, the selected assay measured total enterotoxin (SEA, SEB, SEC, and SED). Addition of <italic>C. scindens</italic> with or without cholic acid significantly diminished total SE production by <italic>S. aureus</italic> compared to cultures without <italic>C. scindens</italic> pre-culture (<italic>p</italic> &#x3d; 0.007, <italic>C. scindens</italic>; <italic>p</italic> &#x3d; 0.012 <italic>C. scindens</italic> &#x2b; cholic acid) (<xref ref-type="fig" rid="F6">Figure 6</xref>). Addition of cholic acid to the luminal reservoir of <italic>S. aureus</italic>/epithelial cell cultures in the absence of <italic>C. scindens</italic> did not significantly alter toxin production compared to the cultures without cholic acid (<italic>p</italic> &#x3d; 0.5) suggesting that cholic acid itself did not modulate toxin production (<xref ref-type="fig" rid="F6">Figure 6</xref>). These results indicate that the production of SE by <italic>S. aureus</italic> was suppressed when <italic>C. scindens</italic> was present, but this suppression was not reliant on the creation of secondary bile acids. Similar findings have been observed in co-cultures of <italic>S. aureus</italic> with other bacterial species <italic>in vitro</italic> (<xref ref-type="bibr" rid="B83">Zdenkova et al., 2016</xref>; <xref ref-type="bibr" rid="B50">Nogueira Vi&#xe7;osa et al., 2019</xref>; <xref ref-type="bibr" rid="B58">Rodr&#xed;guez-S&#xe1;nchez et al., 2022</xref>). However, it is noteworthy that this phenomenon was observed for the first time in <italic>S. aureus-C. scindens</italic> co-culture in the presence of colonic cells.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Measurement of total enterotoxin produced by <italic>S. aureus</italic> in the absence and presence of <italic>C. scindens</italic> &#xb1; cholic acid. The Y-axis is the relative optical density (O.D., 420&#xa0;nm) normalized to an enterotoxin standard, N &#x3d; 5 technical replicates. &#x2a;: <italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;: <italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;: <italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="fbioe-12-1382389-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Culture innovations were made to maintain the viability of epithelial cells in culture with bacteria for 48&#xa0;h when using the O<sub>2</sub> gradient cassette. In contrast, prior cultures of the epithelial cells in the O<sub>2</sub> gradient cassette were heavily damaged at 24&#xa0;h (4, 7). Additionally, prior reports used only a single, probiotic, nonpathogenic bacteria due to the very short lifespan of the epithelial cells under the conditions used. In this study, the obligate anaerobic commensal <italic>C. scindens</italic> was co-cultured with primary human colonic epithelial cells under an O<sub>2</sub> gradient. The O<sub>2</sub> gradient enabled survival of the obligate anaerobic bacteria in the anaerobic microenvironment while providing adequate O<sub>2</sub> concentration for the support of the human cells. Compatibility between the two species (human and microbe) over a 48-h period was shown by the high cell viability, excellent barrier function, appropriate cell morphology, and continued cytokine production. The extended epithelial cell lifetime enabled pre-colonization of the epithelium with a probiotic (<italic>C. scindens</italic>) followed by introduction of a pathogen strain (<italic>S. aureus</italic>) to mimic the sequence of events occurring during intestinal infection <italic>in vivo</italic>. The O<sub>2</sub> gradient cassette is a simple, inexpensive, easy-to-use device that does not require a flow system so that this culture system with extended lifetime is accessible to nonexperts.</p>
<p>When the intestinal pathogen <italic>S. aureus</italic> was inoculated in the luminal compartment at lower density than <italic>C. scindens</italic> under comparable conditions, greater than 60% of the epithelial cells died within 24&#xa0;h. When <italic>S. aureus</italic> was inoculated after establishing an epithelial cells-<italic>C. scindens</italic> co-culture, death of the epithelial cells was greatly reduced and was not significantly different compared with the amount of cell death in the absence of bacteria. These results suggest that the toxicity of <italic>S. aureus</italic> was reduced in the presence of <italic>C. scindens</italic>. Although the growth of <italic>S. aureus</italic> was not noticeably repressed in the presence of <italic>C. scindens</italic>, the concentration of enterotoxin decreased by nearly 50%. <italic>C. scindens</italic> has been reported in multiple <italic>in vitro</italic> studies and an animal study to have an antimicrobial effect on intestinal pathogenic strains (<xref ref-type="bibr" rid="B6">Buffie et al., 2015</xref>; <xref ref-type="bibr" rid="B25">Greathouse et al., 2015</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>; <xref ref-type="bibr" rid="B86">Zhao et al., 2023</xref>). The co-culture results here demonstrate a similar outcome in the presence of primary human colon cells within our <italic>in vitro</italic> platform. These data suggest that the platform could be used to expand the study of antimicrobial effects of intestinal probiotics in an environment more closely mimicking the <italic>in vivo</italic> colonic environment.</p>
<p>Bile acids are known to play important roles in modulating the intestinal microbiome. <italic>C. scindens</italic> converts primary bile acids (cholic and chenodeoxycholic acid) to secondary bile acids (<italic>e.g.</italic>, deoxycholic acid and lithocholic acid) in the intestine (<xref ref-type="bibr" rid="B25">Greathouse et al., 2015</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>). Furthermore, secondary bile acids affect lipid membranes similarly to detergent (<xref ref-type="bibr" rid="B37">Kumar et al., 2020</xref>) and are believed to serve an antimicrobial role within the intestinal microbiome (<xref ref-type="bibr" rid="B56">Ridlon et al., 2016</xref>). In the current study, although <italic>C. scindens</italic> was shown to convert cholic acid to secondary bile acids in the luminal medium, the growth of <italic>S. aureus</italic> was not significantly affected by these bile acid products. This finding was in contrast to prior antimicrobial studies using bile acid supplemented medium, which demonstrated reduced <italic>S. aureus</italic> growth (<xref ref-type="sec" rid="s11">Supplementary Figure S9</xref>). Of note is that these studies did not utilize <italic>C. scindens</italic> for bile acid conversion and epithelial cells were not present. One explanation for the different outcomes could be the transport of secondary bile acids from the luminal to the basal compartment across the epithelial monolayer. In the intestine, &#x3e;95% of bile acids are re-absorbed and then delivered to the liver through the portal vein (<xref ref-type="bibr" rid="B72">Ticho et al., 2019</xref>). In the current studies, the majority of deoxycholic acid, which has a stronger antimicrobial effect on <italic>S. aureus</italic> compared to other secondary bile acids (<xref ref-type="bibr" rid="B31">Kang et al., 2019</xref>), was detected in the basal media. Thus, the decreased concentration of bile acid in the luminal reservoir may have reduced its antimicrobial impact on <italic>S. aureus.</italic> In the presence of the cholic acid in the cultures the dominant species in the basal medium was deoxycholic acid while the apocholic acid was the majority metabolite in the luminal compartment. Apocholic acid is an uncommon bile acid found in human feces and known to be a carcinogenic byproduct resulting from the mild dehydration of cholic acid facilitated by bacterial dehydrogenases (<xref ref-type="bibr" rid="B65">Shi et al., 2023</xref>). While there are no reports of apocholic acid production by <italic>C. scindens</italic>, our findings suggest that the deoxygenation pathway of intestinal bacteria may be influenced by the presence of host cells, a phenomenon not observed in single strain cultures.</p>
<p>Enterotoxin is known to trigger an immune response that leads to damage of intestinal mucosal cells and diarrhea (<xref ref-type="bibr" rid="B20">Fayyaz et al., 2022</xref>). At least 20 types of <italic>S. aureus</italic> enterotoxins with a molecular size of &#x223c;25&#xa0;kDa (220&#x2013;240 amino acids) have been identified (<xref ref-type="bibr" rid="B54">Pinchuk et al., 2010</xref>). The production of enterotoxins is dependent on a variety of parameters, including temperature, pH, and the presence of other microorganisms (<xref ref-type="bibr" rid="B14">Cretenet et al., 2011</xref>; <xref ref-type="bibr" rid="B53">Perales-Ad&#xe1;n et al., 2018</xref>). Recent studies have shown that probiotic isolates can alter biochemical conditions to repress <italic>S. aureus</italic> enterotoxin production in bacterial co-culture <italic>in vitro</italic> without significantly inhibiting the growth of <italic>S. aureus</italic> (<xref ref-type="bibr" rid="B2">Aljasir and D&#x2019;Amico, 2020</xref>). Similar results were observed here in the presence of colonic epithelial cells. Further studies on the role of probiotics in altering the luminal environment in the presence of human epithelium and pathogenic bacteria will be valuable in gaining a better understanding of the interplay of how these cells impact enterotoxin production and activity.</p>
<p>In the colon, stem cells at the base of the intestinal crypts serve to replenish the epithelium as the differentiated cells undergo apoptosis within a few days of migrating to the luminal surface (<xref ref-type="bibr" rid="B76">Wang et al., 2018a</xref>). This process maintains a self-regenerating epithelial monolayer believed to be influenced by intestinal microbiota (<xref ref-type="bibr" rid="B18">Donaldson et al., 2016</xref>). The primary colonic epithelial monolayer used in this study was composed of fully differentiated cells. In the absence of co-cultured bacteria, this monolayer maintains a high TEER barrier for only 2&#x2013;3 days once fully differentiated due to the natural lifetime of differentiated colonic epithelial cells and a lack of proliferative cells that would otherwise maintain the monolayer (<xref ref-type="bibr" rid="B75">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="B76">Wang et al., 2018a</xref>). After this time the TEER drops as the cells begin to die without replacement. The change in TEER over time is consistent with previous studies using soft scaffolds (<xref ref-type="bibr" rid="B27">Gunasekara et al., 2018</xref>; <xref ref-type="bibr" rid="B34">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="B69">Speer et al., 2019</xref>). Future studies are planned with long-lived (&#x3e;30 days) 2D and 3D crypt models that maintain a stem-cell niche to continually support the epithelium (<xref ref-type="bibr" rid="B76">Wang et al., 2018a</xref>; <xref ref-type="bibr" rid="B78">Wang et al., 2022</xref>). These models are expected to sustain epithelial integrity for significantly longer duration and enable the study of more complex microbiota and epithelial interactions.</p>
<p>In this study, fully differentiated, primary human colonic epithelial cells were inoculated with either intestinal probiotic (<italic>C. scindens</italic>), pathogenic (<italic>S. aureus</italic>), or both bacterial species and co-cultured under an O<sub>2</sub> gradient. The O<sub>2</sub> gradient produced the necessary anaerobic environment for the obligate and facultative anaerobic bacteria while maintaining the viability and function of the mammalian cells. The epithelial monolayer retained viability and barrier integrity in the presence of <italic>C. scindens</italic> for 48&#xa0;h but was degraded within 24&#xa0;h in the presence of a smaller inoculum of <italic>S. aureus</italic>. Pre-culturing the epithelium with <italic>C. scindens</italic> reduced the concentration of enterotoxin in subsequent co-culture with <italic>S. aureus</italic> and improved the survival of the epithelial cells but did not inhibit the growth of <italic>S. aureus</italic>. The O<sub>2</sub>-gradient cassette provided an effective and economical platform to study the interactions of intestinal microbiota with primary human cells in an environment more closely mimicking the colonic environment and provides an easy-to-use system for studies of the gut microbiome.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The studies involving humans were approved by University of Washington and University of North Carolina review boards. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from a by-product of routine care or industry. Written informed consent for participation was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and institutional requirements.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>HW: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Validation, Writing&#x2013;original draft, Writing&#x2013;review and editing. RK: Conceptualization, Writing&#x2013;review and editing. YW: Conceptualization, Writing&#x2013;review and editing. KF: Conceptualization, Writing&#x2013;review and editing. CS: Conceptualization, Writing&#x2013;review and editing. NA: Conceptualization, Writing&#x2013;review and editing, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing&#x2013;original draft. RT: Conceptualization, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Institutes of Health under R01DK120606.</p>
</sec>
<ack>
<p>We would like to thank Lauren Shull at the University of Washington for providing materials, and University of Washington Mitochondria and Metabolism Center for technical assistance.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>NA, YW, CS. have a financial interest in Altis Biosystems LLC.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2024.1382389/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2024.1382389/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Al-Jenoobi</surname>
<given-names>F. I.</given-names>
</name>
<name>
<surname>Al-Mohizea</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Everted gut sac model as a tool in pharmaceutical research: limitations and applications</article-title>. <source>J. Pharm. Pharmacol.</source> <volume>64</volume>, <fpage>326</fpage>&#x2013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1111/j.2042-7158.2011.01391.x</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aljasir</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>D&#x2019;amico</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The effect of protective cultures on <italic>Staphylococcus aureus</italic> growth and enterotoxin production</article-title>. <source>Food Microbiol.</source> <volume>91</volume>, <fpage>103541</fpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2020.103541</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Azzouz</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). &#x201c;<article-title>Physiology, large intestine</article-title>,&#x201d; in <source>StatPearls</source> (<publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing LLC</publisher-name>).</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartfeld</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bayram</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Van De Wetering</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Begthel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kujala</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>
<italic>In vitro</italic> expansion of human gastric epithelial stem cells and their responses to bacterial infection</article-title>. <source>Gastroenterology</source> <volume>148</volume>, <fpage>126</fpage>&#x2013;<lpage>136.e6</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2014.09.042</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baruch</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Youngster</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ben-Betzalel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ortenberg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lahat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients</article-title>. <source>Science</source> <volume>371</volume>, <fpage>602</fpage>&#x2013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb5920</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buffie</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Bucci</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Mckenney</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gobourne</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Precision microbiome reconstitution restores bile acid mediated resistance to <italic>Clostridium difficile</italic>
</article-title>. <source>Nature</source> <volume>517</volume>, <fpage>205</fpage>&#x2013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nature13828</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="web">
<collab>CDC</collab> (<year>2018</year>). <article-title>Staphylococcal (staph) food poisoning</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/foodsafety/diseases/staphylococcal.html">https://www.cdc.gov/foodsafety/diseases/staphylococcal.html</ext-link>.</comment>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>761981</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.761981</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The role of gut microbiota in cancer treatment: friend or foe?</article-title> <source>Gut</source> <volume>69</volume>, <fpage>1867</fpage>&#x2013;<lpage>1876</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2020-321153</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Chia</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2023</year>). &#x201c;<article-title>The biological characterization and development of molecular engineering tools for Clostridium scindens</article-title>,&#x201d;. <comment>Master of Science in Engineering</comment> (<publisher-loc>Baltimore, MD, United States</publisher-loc>: <publisher-name>Johns Hopkins University</publisher-name>).</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T. G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Minireview: gut microbiota: the neglected endocrine organ</article-title>. <source>Mol. Endocrinol.</source> <volume>28</volume>, <fpage>1221</fpage>&#x2013;<lpage>1238</lpage>. <pub-id pub-id-type="doi">10.1210/me.2014-1108</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>L. L.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>A guide to Ussing chamber studies of mouse intestine</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>296</volume>, <fpage>G1151</fpage>&#x2013;<lpage>G1166</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.90649.2008</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Co</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Margalef-Catal&#xe0;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mah</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Monack</surname>
<given-names>D. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Controlling epithelial polarity: a human enteroid model for host-pathogen interactions</article-title>. <source>Cell Rep.</source> <volume>26</volume>, <fpage>2509</fpage>&#x2013;<lpage>2520.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.108</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cretenet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Even</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Le Loir</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Unveiling <italic>Staphylococcus aureus</italic> enterotoxin production in dairy products: a review of recent advances to face new challenges</article-title>. <source>Dairy Sci. Technol.</source> <volume>91</volume>, <fpage>127</fpage>&#x2013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1007/s13594-011-0014-9</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dzutsev</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Mcculloch</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Chauvin</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>R. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients</article-title>. <source>Science</source> <volume>371</volume>, <fpage>595</fpage>&#x2013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1126/science.abf3363</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deshmane</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Kremlev</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sawaya</surname>
<given-names>B. E.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Monocyte chemoattractant protein-1 (MCP-1): an overview</article-title>. <source>J. Interferon Cytokine Res.</source> <volume>29</volume>, <fpage>313</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2008.0027</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Ciaula</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garruti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lunardi Baccetto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Molina-Molina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bonfrate</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Bile acid physiology</article-title>. <source>Ann. Hepatol.</source> <volume>16</volume> (<issue>Suppl. 1</issue>), <fpage>S4</fpage>&#x2013;<lpage>S14</lpage>. <pub-id pub-id-type="doi">10.5604/01.3001.0010.5493</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donaldson</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Gut biogeography of the bacterial microbiota</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>14</volume>, <fpage>20</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3552</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutton</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Hinman</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Allbritton</surname>
<given-names>N. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Primary cell-derived intestinal models: recapitulating physiology</article-title>. <source>Trends Biotechnol.</source> <volume>37</volume>, <fpage>744</fpage>&#x2013;<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2018.12.001</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fayyaz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nawaz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Olaimat</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Akram</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Farooq</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Microbial toxins in fermented foods: health implications and analytical techniques for detection</article-title>. <source>J. Food Drug Anal.</source> <volume>30</volume>, <fpage>523</fpage>&#x2013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.38212/2224-6614.3431</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ewing</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Getzenberg</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>Pavlovich</surname>
<given-names>C. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia</article-title>. <source>Prostate</source> <volume>70</volume>, <fpage>473</fpage>&#x2013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1002/pros.21081</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funabashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Varma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mcfadden</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>L. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A metabolic pathway for bile acid dehydroxylation by the gut microbiome</article-title>. <source>Nature</source> <volume>582</volume>, <fpage>566</fpage>&#x2013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2396-4</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Futagami</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hiratsuka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tatsuguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kusunoki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shinji</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Monocyte chemoattractant protein 1 (MCP-1) released from <italic>Helicobacter pylori</italic> stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells</article-title>. <source>Gut</source> <volume>52</volume>, <fpage>1257</fpage>&#x2013;<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1136/gut.52.9.1257</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginos</surname>
<given-names>B. N. R.</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Randolph</surname>
<given-names>T. W.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: a randomized, controlled, crossover feeding study</article-title>. <source>Metabolism</source> <volume>83</volume>, <fpage>197</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2018.02.006</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greathouse</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Bultman</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of <italic>Clostridium difficile</italic>
</article-title>. <source>Cell Metab.</source> <volume>21</volume>, <fpage>9</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.016</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Malagelada</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Gut flora in health and disease</article-title>. <source>Lancet</source> <volume>361</volume>, <fpage>512</fpage>&#x2013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(03)12489-0</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunasekara</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Speer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Smiddy</surname>
<given-names>N. M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>A monolayer of primary colonic epithelium generated on a scaffold with a gradient of stiffness for drug transport studies</article-title>. <source>Anal. Chem.</source> <volume>90</volume>, <fpage>13331</fpage>&#x2013;<lpage>13340</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.8b02845</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scolapio</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Initial evaluation and care of the patient with new-onset intestinal failure</article-title>. <source>Gastroenterol. Clin. North Am.</source> <volume>48</volume>, <fpage>465</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1016/j.gtc.2019.08.001</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinritz</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Mosenthin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Use of pigs as a potential model for research into dietary modulation of the human gut microbiota</article-title>. <source>Nutr. Res. Rev.</source> <volume>26</volume>, <fpage>191</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1017/s0954422413000152</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinman</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Huling</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bretherton</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Deforest</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Magnetically-propelled fecal surrogates for modeling the impact of solid-induced shear forces on primary colonic epithelial cells</article-title>. <source>Biomaterials</source> <volume>276</volume>, <fpage>121059</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121059</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Kakiyama</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>B. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Bile acid 7&#x3b1;-dehydroxylating gut bacteria secrete antibiotics that inhibit <italic>Clostridium difficile</italic>: role of secondary bile acids</article-title>. <source>Cell Chem. Biol.</source> <volume>26</volume>, <fpage>27</fpage>&#x2013;<lpage>34.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2018.10.003</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keeley</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>G. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Defining physiological normoxia for improved translation of cell physiology to animal models and humans</article-title>. <source>Physiol. Rev.</source> <volume>99</volume>, <fpage>161</fpage>&#x2013;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00041.2017</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zha</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. R. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mechanism of the gut microbiota colonization resistance and enteric pathogen infection</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>11</volume>, <fpage>716299</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2021.716299</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Attayek</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Furtado</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>C. E.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>An <italic>in vitro</italic> intestinal platform with a self-sustaining oxygen gradient to study the human gut/microbiome interface</article-title>. <source>Biofabrication</source> <volume>12</volume>, <fpage>015006</fpage>. <pub-id pub-id-type="doi">10.1088/1758-5090/ab446e</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Allbritton</surname>
<given-names>N. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A platform for Co-culture of primary human colonic epithelium with anaerobic probiotic bacteria</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>10</volume>, <fpage>890396</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2022.890396</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Neoh</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Nathan</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Targeting <italic>Staphylococcus aureus</italic> toxins: a potential form of anti-virulence therapy</article-title>. <source>Toxins (Basel)</source> <volume>8</volume>, <fpage>72</fpage>. <pub-id pub-id-type="doi">10.3390/toxins8030072</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19?</article-title> <source>Future Virol.</source> <volume>15</volume>, <fpage>779</fpage>&#x2013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.2217/fvl-2020-0210</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>La Pine</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>H. R.</given-names>
</name>
</person-group> (<year>2011</year>). &#x201c;<article-title>148 - host defense mechanisms against bacteria</article-title>,&#x201d; in <source>Fetal and neonatal physiology</source>. Editors <person-group person-group-type="editor">
<name>
<surname>POLIN</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>FOX</surname>
<given-names>W. W.</given-names>
</name>
<name>
<surname>ABMAN</surname>
<given-names>S. H.</given-names>
</name>
</person-group> <edition>Fourth Edition</edition> (<publisher-loc>Philadelphia</publisher-loc>: <publisher-name>W.B. Saunders</publisher-name>).</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Current <italic>in vitro</italic> and animal models for understanding foods: human gut-microbiota interactions</article-title>. <source>J. Agric. Food Chem.</source> <volume>70</volume>, <fpage>12733</fpage>&#x2013;<lpage>12745</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.2c04238</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marion</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Desharnais</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Menin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Escrig</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meibom</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> characterization of Clostridium scindens bile acid transformations</article-title>. <source>Gut Microbes</source> <volume>10</volume>, <fpage>481</fpage>&#x2013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2018.1549420</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pujol-Vila</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Illa</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Elizalde-Torrent</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Gut-on-a-chip: mimicking and monitoring the human intestine</article-title>. <source>Biosens. Bioelectron.</source> <volume>181</volume>, <fpage>113156</fpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2021.113156</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martens</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Seys</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Alpizar</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>Schrijvers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bullens</surname>
<given-names>D. M. A.</given-names>
</name>
<name>
<surname>Breynaert</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>
<italic>Staphylococcus aureus</italic> enterotoxin B disrupts nasal epithelial barrier integrity</article-title>. <source>Clin. Exp. Allergy</source> <volume>51</volume>, <fpage>87</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1111/cea.13760</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mcneil</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Capaldo</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Macara</surname>
<given-names>I. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Zonula occludens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells</article-title>. <source>Mol. Biol. Cell</source> <volume>17</volume>, <fpage>1922</fpage>&#x2013;<lpage>1932</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e05-07-0650</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mekhjian</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>A. F.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Colonic absorption of unconjugated bile acids: perfusion studies in man</article-title>. <source>Dig. Dis. Sci.</source> <volume>24</volume>, <fpage>545</fpage>&#x2013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1007/bf01489324</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moret&#xf3;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>P&#xe9;rez-Bosque</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Dietary plasma proteins, the intestinal immune system, and the barrier functions of the intestinal mucosa</article-title>. <source>J. Anim. Sci.</source> <volume>87</volume>, <fpage>E92</fpage>&#x2013;<lpage>E100</lpage>. <pub-id pub-id-type="doi">10.2527/jas.2008-1381</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>G. N.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cato</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Bokkenheuser</surname>
<given-names>V. D.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Clostridium scindens sp. nov., a human intestinal bacterium with desmolytic activity on corticoids</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source> <volume>35</volume>, <fpage>478</fpage>&#x2013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1099/00207713-35-4-478</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morvan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Folgosa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kint</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martin-Verstraete</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Responses of Clostridia to oxygen: from detoxification to adaptive strategies</article-title>. <source>Environ. Microbiol.</source> <volume>23</volume>, <fpage>4112</fpage>&#x2013;<lpage>4125</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.15665</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarro</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Elkon</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kahsai</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Ammar</surname>
<given-names>H. S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effect of a flaxseed lignan intervention on circulating bile acids in a placebo-controlled randomized, crossover trial</article-title>. <source>Nutrients</source> <volume>12</volume>, <fpage>1837</fpage>. <pub-id pub-id-type="doi">10.3390/nu12061837</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Vieira-Silva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>How informative is the mouse for human gut microbiota research?</article-title> <source>Dis. Model Mech.</source> <volume>8</volume>, <fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.017400</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogueira Vi&#xe7;osa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vieira Botelho</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Botta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fernandes De Carvalho</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nero</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Impact of co-cultivation with <italic>Enterococcus faecalis</italic> over growth, enterotoxin production and gene expression of <italic>Staphylococcus aureus</italic> in broth and fresh cheeses</article-title>. <source>Int. J. Food Microbiol.</source> <volume>308</volume>, <fpage>108291</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2019.108291</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Gara</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Into the storm: chasing the opportunistic pathogen <italic>Staphylococcus aureus</italic> from skin colonisation to life-threatening infections</article-title>. <source>Environ. Microbiol.</source> <volume>19</volume>, <fpage>3823</fpage>&#x2013;<lpage>3833</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.13833</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Payne</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Zihler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chassard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lacroix</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Advances and perspectives in <italic>in vitro</italic> human gut fermentation modeling</article-title>. <source>Trends Biotechnol.</source> <volume>30</volume>, <fpage>17</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2011.06.011</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perales-Ad&#xe1;n</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rubi&#xf1;o</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Bueno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valdivia</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Montalb&#xe1;n-L&#xf3;pez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cebri&#xe1;n</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>LAB bacteriocins controlling the food isolated (Drug-Resistant) staphylococci</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <fpage>1143</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.01143</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinchuk</surname>
<given-names>I. V.</given-names>
</name>
<name>
<surname>Beswick</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>V. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Staphylococcal enterotoxins</article-title>. <source>Toxins</source> <volume>2</volume>, <fpage>2177</fpage>&#x2013;<lpage>2197</lpage>. <pub-id pub-id-type="doi">10.3390/toxins2082177</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghiboub</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Donkers</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Van De Steeg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Van Tol</surname>
<given-names>E. A. F.</given-names>
</name>
<name>
<surname>Hakvoort</surname>
<given-names>T. B. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The progress of intestinal epithelial models from cell lines to gut-on-chip</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <fpage>13472</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222413472</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridlon</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Bhowmik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Hylemon</surname>
<given-names>P. B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Consequences of bile salt biotransformations by intestinal bacteria</article-title>. <source>Gut Microbes</source> <volume>7</volume>, <fpage>22</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2015.1127483</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridlon</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Hylemon</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Bajaj</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Bile acids and the gut microbiome</article-title>. <source>Curr. Opin. Gastroenterol.</source> <volume>30</volume>, <fpage>332</fpage>&#x2013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1097/mog.0000000000000057</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-S&#xe1;nchez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-P&#xe9;rez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Poveda</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Sese&#xf1;a</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Palop</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Lactic acid bacteria as biocontrol agents to reduce <italic>Staphylococcus aureus</italic> growth, enterotoxin production and virulence gene expression</article-title>. <source>LWT</source> <volume>170</volume>, <fpage>114025</fpage>. <pub-id pub-id-type="doi">10.1016/j.lwt.2022.114025</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roodsant</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Navis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aknouch</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Renes</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Van Elburg</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Pajkrt</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A human 2D primary organoid-derived epithelial monolayer model to study host-pathogen interaction in the small intestine</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>, <fpage>272</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.00272</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rooks</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Garrett</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Gut microbiota, metabolites and host immunity</article-title>. <source>Nat. Rev. Immunol.</source> <volume>16</volume>, <fpage>341</fpage>&#x2013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.42</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roura</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Koopmans</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Lall&#xe8;s</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Le Huerou-Luron</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>De Jager</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schuurman</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Critical review evaluating the pig as a model for human nutritional physiology</article-title>. <source>Nutr. Res. Rev.</source> <volume>29</volume>, <fpage>60</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1017/s0954422416000020</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sannasiddappa</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>In vitro</italic> antibacterial activity of unconjugated and conjugated bile salts on <italic>Staphylococcus aureus</italic>
</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>, <fpage>1581</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.01581</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Maslowski</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kanai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Development of a scalable coculture system for gut anaerobes and human colon epithelium</article-title>. <source>Gastroenterology</source> <volume>159</volume>, <fpage>388</fpage>&#x2013;<lpage>390.e5</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2020.03.021</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwerdtfeger</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Nealon</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Tobet</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Human colon function <italic>ex vivo</italic>: dependence on oxygen and sensitivity to antibiotic</article-title>. <source>PLoS One</source> <volume>14</volume>, <fpage>e0217170</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0217170</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Antimicrobial peptides act on the rumen microbiome and metabolome affecting the performance of castrated bulls</article-title>. <source>J. Anim. Sci. Biotechnol.</source> <volume>14</volume>, <fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/s40104-023-00832-5</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shu</surname>
<given-names>L. Z.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y. D.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Q. M.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier</article-title>. <source>Ther. Adv. Gastroenterol.</source> <volume>16</volume>, <fpage>175628482311764</fpage>. <pub-id pub-id-type="doi">10.1177/17562848231176427</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sivan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Corrales</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hubert</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Aquino-Michaels</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Earley</surname>
<given-names>Z. M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy</article-title>. <source>Science</source> <volume>350</volume>, <fpage>1084</fpage>&#x2013;<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1126/science.aac4255</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sommer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>B&#xe4;ckhed</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The gut microbiota--masters of host development and physiology</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>11</volume>, <fpage>227</fpage>&#x2013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2974</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Speer</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Gunasekara</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fallon</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Attayek</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>P. C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Molecular transport through primary human small intestinal monolayers by culture on a collagen scaffold with a gradient of chemical cross-linking</article-title>. <source>J. Biol. Eng.</source> <volume>13</volume>, <fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/s13036-019-0165-4</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubbendieck</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Straight</surname>
<given-names>P. D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Multifaceted interfaces of bacterial competition</article-title>. <source>J. Bacteriol.</source> <volume>198</volume>, <fpage>2145</fpage>&#x2013;<lpage>2155</lpage>. <pub-id pub-id-type="doi">10.1128/jb.00275-16</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#x160;uligoj</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vigsn&#xe6;s</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Abbeele</surname>
<given-names>P. V. D.</given-names>
</name>
<name>
<surname>Apostolou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karalis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Savva</surname>
<given-names>G. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effects of human milk oligosaccharides on the adult gut microbiota and barrier function</article-title>. <source>Nutrients</source> <volume>12</volume>, <fpage>2808</fpage>. <pub-id pub-id-type="doi">10.3390/nu12092808</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ticho</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dudeja</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Alrefai</surname>
<given-names>W. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Intestinal absorption of bile acids in health and disease</article-title>. <source>Compr. Physiol.</source> <volume>10</volume>, <fpage>21</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c190007</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tovaglieri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sontheimer-Phelps</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Geirnaert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prantil-Baun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Camacho</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>D. B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Species-specific enhancement of enterohemorrhagic <italic>E. coli</italic> pathogenesis mediated by microbiome metabolites</article-title>. <source>Microbiome</source> <volume>7</volume>, <fpage>43</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-019-0650-5</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Verhoeckx</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Exp&#xf3;sito</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kleiveland</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lea</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mackie</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <source>The Impact of Food Bioactives on Health: <italic>in vitro</italic> and <italic>ex vivo</italic> models</source>. <publisher-name>Springer International Publishing</publisher-name>.</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Disalvo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gunasekara</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Dutton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Proctor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lebhar</surname>
<given-names>M. S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Self-renewing monolayer of primary colonic or rectal epithelial cells</article-title>. <source>Cell Mol. Gastroenterol. Hepatol.</source> <volume>4</volume>, <fpage>165</fpage>&#x2013;<lpage>182.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2017.02.011</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gunasekara</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Disalvo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>D. L.</given-names>
</name>
<etal/>
</person-group> (<year>2018a</year>). <article-title>Formation of human colonic crypt array by application of chemical gradients across a shaped epithelial monolayer</article-title>. <source>Cell Mol. Gastroenterol. Hepatol.</source> <volume>5</volume>, <fpage>113</fpage>&#x2013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2017.10.007</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Dutton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Allbritton</surname>
<given-names>N. L.</given-names>
</name>
</person-group> (<year>2018b</year>). <article-title>Analysis of interleukin 8 secretion by a stem-cell-derived human-intestinal-epithelial-monolayer platform</article-title>. <source>Anal. Chem.</source> <volume>90</volume>, <fpage>11523</fpage>&#x2013;<lpage>11530</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.8b02835</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Allbritton</surname>
<given-names>N. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Human 2D crypt model for assaying intestinal stem cell proliferation and differentiation</article-title>. <source>Anal. Chem.</source> <volume>94</volume>, <fpage>9345</fpage>&#x2013;<lpage>9354</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.2c00905</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Lipsky</surname>
<given-names>W. R. L.</given-names>
</name>
<name>
<surname>Fricke</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Hylemon</surname>
<given-names>P. B.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Bile acid induction specificity of 7 alpha-dehydroxylase activity in an intestinal Eubacterium species</article-title>. <source>Steroids</source> <volume>35</volume>, <fpage>103</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/0039-128x(80)90115-4</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Samsa</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Disalvo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cocchiaro</surname>
<given-names>J. L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology</article-title>. <source>Cell Mol. Gastroenterol. Hepatol.</source> <volume>6</volume>, <fpage>301</fpage>&#x2013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2018.05.004</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wlodarska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kolde</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>D&#x2019;Hennezel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Annand</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Heim</surname>
<given-names>C. E.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation</article-title>. <source>Cell Host Microbe</source> <volume>22</volume>, <fpage>25</fpage>&#x2013;<lpage>37.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2017.06.007</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Y. H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology</article-title>. <source>World J. Gastrointest. Pathophysiol.</source> <volume>3</volume>, <fpage>27</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.4291/wjgp.v3.i1.27</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zdenkova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alibayov</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Karamonova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Purkrtova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karpiskova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Demnerova</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Transcriptomic and metabolic responses of <italic>Staphylococcus aureus</italic> in mixed culture with Lactobacillus plantarum, Streptococcus thermophilus and Enterococcus durans in milk</article-title>. <source>J. Ind. Microbiol. Biotechnol.</source> <volume>43</volume>, <fpage>1237</fpage>&#x2013;<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-016-1794-y</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hernandez-Gordillo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Trapecar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Taketani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Coculture of primary human colon monolayer with human gut bacteria</article-title>. <source>Nat. Protoc.</source> <volume>16</volume>, <fpage>3874</fpage>&#x2013;<lpage>3900</lpage>. <pub-id pub-id-type="doi">10.1038/s41596-021-00562-w</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kemmitt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive faecalibacterium prausnitzii in continuous culture</article-title>. <source>Med</source> <volume>2</volume>, <fpage>74</fpage>&#x2013;<lpage>98.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.medj.2020.07.001</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Gut microbiota-mediated secondary bile acid alleviates Staphylococcus aureus-induced mastitis through the TGR5-cAMP-PKA-NF-&#x3ba;B/NLRP3 pathways in mice</article-title>. <source>NPJ Biofilms Microbiomes</source> <volume>9</volume>, <fpage>8</fpage>. <pub-id pub-id-type="doi">10.1038/s41522-023-00374-8</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>